Lambré Claude, Barat Baviera José Manuel, Bolognesi Claudia, Cocconcelli Pier Sandro, Crebelli Riccardo, Gott David Michael, Grob Konrad, Lampi Evgenia, Mengelers Marcel, Mortensen Alicja, Rivière Gilles, Steffensen Inger-Lise, Tlustos Christina, Van Loveren Henk, Vernis Laurence, Zorn Holger, Glandorf Boet, Herman Lieve, Roos Yrjö, Kovalkovičová Natália, Liu Yi, Lunardi Simone, Di Piazza Giulio, de Sousa Rita Ferreira, Chesson Andrew
EFSA J. 2022 Dec 9;20(12):e07676. doi: 10.2903/j.efsa.2022.7676. eCollection 2022 Dec.
The food enzyme containing cellulase (EC 3.2.1.4), endo-1,3(4)-β-glucanase (EC 3.2.1.6) and endo-1,4-β-xylanase (EC 3.2.1.8) is produced with the non-genetically modified strain AR-256 by AB-Enzymes GmbH. The food enzyme is considered free from viable cells of the production organism. It is intended to be used in seven food manufacturing processes: baking processes, cereal-based processes, brewing processes, fruit and vegetable processing for juice production, wine and wine vinegar production, distilled alcohol production and grain treatment for production of starch and gluten fractions. Since the residual amounts of total organic solids (TOS) are removed during grain treatment and distilled alcohol production, dietary exposure was estimated for the remaining five processes and amounted up to 3.92 mg TOS/kg body weight (bw) per day. The toxicity studies were carried out with an endo-1,4-β-xylanase from ■■■■■, considered by the Panel as a suitable substitute, because the genetic differences between the strains are well characterised and of no concern. Additionally, several strains derived from the production strain are considered safe by EFSA and the manufacturing of both food enzymes is similar. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by a repeated dose 90-day oral toxicity rat study. The no observed adverse effect level of 939 mg TOS/kg bw per day, the highest dose tested, compared with the estimated dietary exposure, resulted in a margin of exposure above 239. In the search for the similarity of the amino acid sequences to known allergens, one match (salmon) was found. The Panel considered that, under the intended conditions of use (except distilled alcohol production), the risk of allergic reactions by dietary exposure cannot be excluded, in particular for individuals sensitised to salmon. The Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.
含有纤维素酶(EC 3.2.1.4)、内切-1,3(4)-β-葡聚糖酶(EC 3.2.1.6)和内切-1,4-β-木聚糖酶(EC 3.2.1.8)的食品酶由AB-Enzymes GmbH公司使用非转基因菌株AR-256生产。该食品酶被认为不含生产生物体的活细胞。它拟用于七种食品制造工艺:烘焙工艺、谷物加工工艺、酿造工艺、用于果汁生产的果蔬加工、葡萄酒和葡萄酒醋生产、蒸馏酒精生产以及用于淀粉和麸质组分生产的谷物处理。由于在谷物处理和蒸馏酒精生产过程中总有机固体(TOS)的残留量被去除,因此对其余五个工艺进行了膳食暴露评估,结果为每天高达3.92毫克TOS/千克体重(bw)。毒性研究使用了来自■■■■■的内切-1,4-β-木聚糖酶进行,专家小组认为该酶是合适的替代品,因为菌株之间的遗传差异已得到充分表征且无问题。此外,欧洲食品安全局认为源自生产菌株的几种菌株是安全的,并且两种食品酶的生产过程相似。遗传毒性试验未表明存在安全问题。通过一项为期90天的大鼠重复剂量口服毒性研究评估了全身毒性。所测试的最高剂量为每天939毫克TOS/千克体重,未观察到不良影响水平,与估计的膳食暴露相比,暴露边际高于239。在寻找与已知过敏原氨基酸序列的相似性时,发现了一个匹配项(鲑鱼)。专家小组认为,在预期的使用条件下(蒸馏酒精生产除外),不能排除因膳食暴露引起过敏反应的风险,特别是对于对鲑鱼过敏的个体。专家小组得出结论,在预期的使用条件下,这种食品酶不会引起安全问题。